Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathwaysMaristella Bungaro, Consuelo Buttigliero, Marcello TucciTranslational Lung Cancer Research|February 3, 2017
Anti-angiogenetic therapies for central nervous system metastases from non-small cell lung cancerConsuelo Buttigliero, Valentina Bertaglia, Silvia NovelloResearch and Reports in Urology|October 6, 2022
Treatment Landscape for Patients with Castration-Resistant Prostate Cancer: Patient Selection and Unmet Clinical NeedsFabio Turco, Silke Gillessen, Richard Cathomas, et al.Clinical Nuclear Medicine|April 2, 2019
68Ga-PSMA Uptake in Fibrous DysplasiaMaria Lucia Reale, Consuelo Buttigliero, Marcello Tucci, et al.Clinical Nuclear Medicine|February 7, 2017
223Ra Dichloride Bone-Targeted Therapy in a Case of Metastatic Salivary Duct CarcinomaMatteo Manfredi, Mario Airoldi, Marcello Tucci, et al.Cancer Treatment Reviews|January 31, 2017
Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancerConsuelo Buttigliero, Marcello Tucci, Francesca Vignani, et al.Cancer Treatment Reviews|February 25, 2016
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancerFrancesca Vignani, Valentina Bertaglia, Consuelo Buttigliero, et al.The Oncologist|August 13, 2011
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic reviewConsuelo Buttigliero, Chiara Monagheddu, Paola Petroni, et al.Current Oncology (Toronto, Ont.)|December 22, 2022
Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and MetanalysisFrancesco Fiorica, Consuelo Buttigliero, Daniela Grigolato, et al.Oncotargets and Therapy|November 15, 2018
Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutionsMarcello Tucci, Clizia Zichi, Consuelo Buttigliero, et al.Pageof 9